Biotech Newswire
Search
Editor Sign-up
Request Demo
Request Pricing
Search
HOME
NEWSROOM
FAQ
DISTRIBUTION OPTIONS
ARTIFICIAL INTELLIGENCE
The
life science
and biotech PR distribution service
All Biotech News
List of articles in category All Biotech News
Title
Published Date
Deuterium Depletion Is the Key to Getting a Breakthrough in Cancer Therapy
07/25/2024
Plexium Selects Xavo as their Sample Management Lab Operations Platform
07/24/2024
New Facility Assures Continuity of Supply of Anti-Obesity Treatment CONTRAVE®/MYSIMBA® Amidst GLP-1 Supply Issues
07/23/2024
Touchlight and GSK Sign License Agreement for Use of Enzymatic dbDNA Production Technology for mRNA Manufacturing
07/23/2024
Medway NHS Foundation Trust to Transform Local Gestational Diabetes Screening by Offering World-First Home Oral Glucose Tolerance Testing (OGTT) Technology to All At-Risk Women
07/22/2024
Dermaliq Therapeutics Announces Positive Topline Results from Phase 1b/2a Trial Evaluating the Safety and Efficacy of DLQ01 for the Treatment of Androgenetic Alopecia (AGA) in Men
07/16/2024
MIMETAS Contributes with Human Organ-on-Chip Data to IND Application by argenx
07/11/2024
AzarGen Presents AZprom™ - Superior Synthetic Promotors to Enhance Molecular Farming Applications
07/09/2024
SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases
07/09/2024
Eleva Receives Orphan Drug Designation in Europe for Proprietary Factor H Therapy in C3 Glomerulopathy (C3G)
07/03/2024
Touchlight and LenioBio Collaborate to Accelerate Development of Protein Therapeutics for Pandemic Response
07/02/2024
Celonic Inaugurates “Next Generation” Biologics Development Center (BDC) and Pilot Plant in Basel, Switzerland
06/18/2024
NXI Therapeutics Extends Pre-Seed Financing to CHF 3.5 Million in Run-up to Larger Seed Financing
06/18/2024
SciRhom Announces Approval of First Clinical Trial Application for a Novel iRhom2-targeting Antibody Against Autoimmune Diseases
06/12/2024
Freudenberg Medical Expands Coatings Business with New Production Facility
06/11/2024
Vetter Announces Plans to Expand Its Capacity in the U.S. and Germany
06/06/2024
Atriva Therapeutics Secures US Patent for MEK Inhibitor Zapnometinib (ATR-002), a First-in-Class Broad Spectrum Therapy for Severe RNA Virus Infections Including Bird Flu (H5N1)
06/06/2024
Sartorius Opens New Center of Excellence for Bioanalytics in Ann Arbor
06/05/2024
Annogen Announces Research Collaboration with Orchard Therapeutics for the Development of CNS-cell Specific Promoters
06/04/2024
ModeX Therapeutics Leverages ProBioGen's Expertise for Accelerated COVID-19 Antibody Development
05/29/2024
Vetter Wins Best Managed Companies Award 2024
05/28/2024
New CRO Focused on Cannabis-based Drug Trials Launched
05/22/2024
Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA
05/16/2024
NEOsphere Biotechnologies Partners with Kymera Therapeutics for Novel Molecular Glue Target Discovery
05/14/2024
Sartorius Collaborates with Sanofi to Commercialize End-To-End Platform for Downstream Process Intensification
05/13/2024
Touchlight Genetics and the National Physical Laboratory (NPL) Awarded Grant to Develop Novel Gene-Length Single-Stranded Genome Editing Template
05/09/2024
On the Path to Net Zero: Vetter Achieves New Sustainability Goals in 2023
05/08/2024
Glucagon-like peptide-1 (GLP-1) Receptor Agonist Semaglutide in an Oleogel Formulation Using the BrainDos™ Technology Significantly Increases Drug Delivery into Cells
05/08/2024
First Commercial Cell and Gene Therapy Product Manufactured at Minaris Regenerative Medicine in Allendale, NJ.
05/08/2024
Change in Management
04/30/2024
Page 8 of 87
Start
Prev
3
4
5
6
7
8
9
10
11
12
Next
End